PARP1 and urinary bladder carcinoma: Loss of p53 function associated with increased PARP-1 expression in bladder cancer cell lines and tumors, supporting a model in which perturbed ROS regulation in cells with mutated TP53 require PARP-1 for survival in response to cytotoxic insults (Figure 1).